We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+6.14%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$45.6B
AUM Growth
+$1.67B
(+3.8%)
Cap. Flow
+$118M
Cap. Flow
% of AUM
0.26%
Top 10 Holdings %
Top 10 Hldgs %
14.15%
Holding
2,318
New
125
Increased
935
Reduced
1,083
Closed
165
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$163M |
| 2 |
American International
AIG
|
+$149M |
| 3 |
Walmart Inc
WMT
|
+$129M |
| 4 |
General Motors
GM
|
+$106M |
| 5 |
Synchrony
SYF
|
+$96.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$144M |
| 2 |
Wells Fargo
WFC
|
+$139M |
| 3 |
AT&T
T
|
+$109M |
| 4 |
Expedia Group
EXPE
|
+$70.5M |
| 5 |
Micron Technology
MU
|
+$67M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.45% |
| 2 | Healthcare | 14.87% |
| 3 | Industrials | 12.06% |
| 4 | Consumer Discretionary | 11.94% |
| 5 | Financials | 10.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
SIGA Technologies
SIGA
$211M
| $84.8K | ﹤0.01% |
14,743
-1,050
| -7% | -$7.01K |
|
2127
Relmada Therapeutics
RLMD
$484M
| $83.6K | ﹤0.01% |
36,991
+6,648
| +22% | +$22.9K |
|
2128
Custom Truck One Source
CTOS
$2.42B
| $81K | ﹤0.01% |
11,927
+42
| +0.4% | +$292 |
|
|
PNT
2129
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $76.4K | ﹤0.01% |
10,508
-107
| -1% | -$794 |
|
2130
Kinross Gold
KGC
$32.5B
| $76.1K | ﹤0.01% |
16,156
-7,397
| -31% | -$31.3K |
|
|
BRFS
2131
DELISTED
BRF SA
BRFS
| $69.9K | ﹤0.01% |
54,574
-21,530
| -28% | -$30.3K |
|
|
AMPS
2132
DELISTED
Altus Power
AMPS
| $68.1K | ﹤0.01% |
12,420
-9,425
| -43% | -$66.1K |
|
2133
AvePoint
AVPT
$2.75B
| $65.9K | ﹤0.01% |
15,991
-2,565
| -14% | -$11.6K |
|
2134
Arbutus Biopharma
ABUS
$907M
| $63.4K | ﹤0.01% |
20,935
-1,818
| -8% | -$5.13K |
|
2135
Praxis Precision Medicines
PRAX
$10.2B
| $60.3K | ﹤0.01% |
4,973
-5,729
| -54% | -$242K |
|
2136
Gevo
GEVO
$388M
| $59.8K | ﹤0.01% |
38,825
+1,104
| +3% | +$2.09K |
|
2137
Opko Health
OPK
$1.04B
| $59.5K | ﹤0.01% |
40,772
-37,566
| -48% | -$48.4K |
|
2138
The RealReal
REAL
$1.45B
| $58.7K | ﹤0.01% |
+46,591
| New | +$67.6K |
|
|
VRAY
2139
DELISTED
ViewRay, Inc.
VRAY
| $54.6K | ﹤0.01% |
15,780
-6,724
| -30% | -$28.5K |
|
2140
AirSculpt Technologies
AIRS
$194M
| $53.3K | ﹤0.01% |
+10,582
| New | +$58.5K |
|
2141
Brookdale Senior Living
BKD
$3.27B
| $53.3K | ﹤0.01% |
+18,070
| New | +$51.9K |
|
2142
Xeris Biopharma Holdings
XERS
$1.46B
| $51.5K | ﹤0.01% |
31,566
-18,688
| -37% | -$23.4K |
|
|
SLGC
2143
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $46.4K | ﹤0.01% |
18,214
-96,711
| -84% | -$277K |
|
2144
Workhorse Group
WKHS
$34.5M
| $44.9K | ﹤0.01% |
11
+3
| +38% | +$16.6K |
|
2145
Cadiz
CDZI
$279M
| $43.9K | ﹤0.01% |
10,859
| – | – |
|
2146
Microvast
MVST
$291M
| $42K | ﹤0.01% |
+33,877
| New | +$49.2K |
|
2147
Ouster
OUST
$3.04B
| $37.1K | ﹤0.01% |
+4,430
| New | +$51.4K |
|
|
WE
2148
DELISTED
WeWork Inc.
WE
| $36.8K | ﹤0.01% |
1,184
+878
| +287% | +$48K |
|
|
CANO
2149
DELISTED
Cano Health, Inc.
CANO
| $33.1K | ﹤0.01% |
364
-191
| -34% | -$25.9K |
|
2150
Instil Bio
TIL
$50.3M
| $25.7K | ﹤0.01% |
1,946
+1,321
| +211% | +$19.5K |
|
Similar funds
VGA
AQR Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, AQR Capital Management held 2,318 positions worth $45.6B, up 3.8% from $43.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management's Q1 2023 filing shows 125 new, 935 increased, 1,083 reduced and 165 closed positions. Its largest new stake was GE HealthCare: 300,492 shares worth $24.6M. The largest sale was Meta Platforms (Facebook), an estimated $144M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Industrials.
- AQR Capital Management's largest Q1 2023 buy was GE HealthCare: 300,492 shares worth $24.6M.
- AQR Capital Management added most to Cigna in Q1 2023, an estimated $163M increase.
- AQR Capital Management's biggest Q1 2023 reduction was Meta Platforms (Facebook), cutting an estimated $144M.
- AQR Capital Management fully exited Signature Bank in Q1 2023, selling an estimated $18.8M.
- AQR Capital Management's ten largest holdings make up 14% of its $45.6B portfolio in Q1 2023.
- AQR Capital Management opened 125 new positions and closed 165 in Q1 2023.
- AQR Capital Management's portfolio value rose 3.8% quarter-over-quarter to $45.6B.
Based on AQR Capital Management's 13F filing for Q1 2023, filed 15 May 2023.